This content is from: Premium Short Sellers Won in Mallinckrodt Mess, but Some Hedgies Held On The specialty pharmaceutical company settled opioid lawsuit and is considering restructuring. By Michelle Celarier September 10, 2019
This content is from: Premium Larry Robbins Posts Big Gains in April The manager trimmed health care stocks, but sinking holdings have still left Glenview down by double digits. By Michelle Celarier May 28, 2020
This content is from: Premium Bill Ackman Finishes 2019 With a Bang Pershing Square triumphs, making back four years of losses — and earning incentive fees. By Michelle Celarier January 03, 2020
This content is from: Portfolio Morning Brief: Suddenly Valeant’s Stock is Surging Shares of Valeant Pharmaceuticals International jumped more than 23 percent in just three days. By Stephen Taub November 09, 2017
This content is from: Premium Bill Ackman Has Some Advice for You — and It’s Not About Your Portfolio The Pershing Square CEO opined on life, love, and the pursuit of profit at an investment conference in Manhattan. By Michelle Celarier April 17, 2019
Sponsored Stability Amidst Risk and Volatility Multi-asset risk mitigation strategies are in demand in trying times. Here’s why. Sponsored by Invesco July 28, 2020
Sponsored You Still Need to Strengthen Portfolio Resilience How COVID-19 will play out remains uncertain. Multi-asset strategies have the flexibility and potential to address risks as they evolve. Sponsored by Invesco July 28, 2020
